Vital Farms: The Recovery Is Starting, But I Need More Proof (NASDAQ:VITL)
Vital Farms (VITL) reported a challenging Q2 with a 10% revenue decline and a significant drop in gross margin to 6.6%, alongside substantial cash burn. Despite this, the company beat revenue expectations and reaffirmed full-year guidance, showing initial signs of stabilization in price gaps and supply. While management anticipates gross margin recovery to around 30% by Q4, a return to historical 35-40% margins is deemed unlikely, leading the analyst to maintain a Hold rating pending further proof of sustained improvement.
Vital Farms : VITL
This article provides an overview of Vital Farms Inc. (VITL), an Austin, Texas-based food company known for its commitment to ethical farming practices and pasture-raised products. It includes stock data for VITL, showing its current trading price and sector, and lists one related article discussing Beyond Meat's stock performance. The page also features other trending financial articles.
Form 8K Vital Farms Inc For: 17 August By Investing.com
This article reports on a Form 8K filing by Vital Farms Inc. on August 17. The filing is a standard disclosure required by the SEC for significant events. The article provides the company's stock symbol (VITL) and its current performance.
Vital Farms : VITL
This article provides an overview of Vital Farms Inc (VITL), an Austin, Texas-based food company known for its ethical farming practices and pasture-raised products like eggs and butter. It includes current stock data for VITL, showing a price of $10.98, and lists a related article discussing Beyond Meat's stock performance. The page also features trending articles on various financial and economic topics.
Vital Farms amends 8-K to add missing Item 5.03 in EDGAR header
Vital Farms has filed an amended Form 8-K to correct a minor omission in its EDGAR header. The amendment specifically adds the missing Item 5.03 reference, with no other changes made to the original filing. This correction relates to the company's adoption of amended and restated bylaws that became effective on August 11, 2026.
Form 8K Vital Farms Inc For: 17 August By Investing.com
This article reports on Vital Farms Inc.'s Form
ETFs Investing in Vital Farms, Inc. Stocks
This article lists Exchange Traded Funds (ETFs) that hold Vital Farms, Inc. (5KH) stocks, providing investors with options to gain exposure to the company. The list includes details such as market value, weight, issuer, management style, expense ratio, assets under management (AUM), and price performance for each ETF. These ETFs offer opportunities for diversified investing in Vital Farms, Inc. with potentially lower risk.
VITL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) and some of its officers. The lawsuit alleges that Vital Farms made false and misleading statements regarding delays and impact of its new enterprise resource planning (ERP) system, leading to missed full-year earnings guidance. Investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, are encouraged to join the lawsuit by May 26, 2026, to request lead plaintiff status.
Vital Farms (NASDAQ:VITL) Upgraded at Zacks Research
Zacks Research upgraded Vital Farms (NASDAQ:VITL) from a "strong sell" to a "hold" rating, while the average analyst consensus remains "hold" with a $17.18 price target. The company reported quarterly revenue of $166.03 million, exceeding estimates, but experienced a 10.2% year-over-year revenue decline and an adjusted loss of $0.47 per share. Insiders purchased 35,700 shares, and institutional investors hold a significant 98.59% of the stock.
Needham & Company LLC Issues Positive Forecast for Vital Farms (NASDAQ:VITL) Stock Price
Needham & Company LLC has raised its price target for Vital Farms (NASDAQ:VITL) to $14 from $13, maintaining a "buy" rating and indicating a potential upside of 11.76%. This positive forecast comes despite mixed analyst sentiment, with the company reporting a quarterly loss of $0.47 per share and a 10.2% year-over-year revenue decline, even as revenue exceeded consensus estimates. Insider buying and increased institutional ownership are noted, alongside an average "Hold" rating from analysts with a consensus price target of $21.25.
Vital Farms, Inc. Stock 12‑Month Price Target Raised to $12.89, Implies 5% Upside
Vital Farms, Inc.'s average stock price target has increased to $12.89 from $12, according to estimates from nine analysts, with forecasts ranging from $10 to $18 per share. This updated target suggests a potential upside of approximately 5% based on the August 5 closing price. The consensus rating for VITL remains "Buy" among ten covering analysts, with four recommending "Buy" and six recommending "Hold."
Dimensional Fund Advisors LP Purchases 447,728 Shares of Vital Farms, Inc. $VITL
Dimensional Fund Advisors LP increased its stake in Vital Farms, Inc. by 46.8% in the first quarter, purchasing an additional 447,728 shares. This makes their total holding 1,405,032 shares, valued at $19.836 million. The article also notes recent insider buying activity and mixed analyst sentiment on Vital Farms, despite the company reporting second-quarter revenue that topped expectations.
Vital Farms, Inc. Q2 2026: Revenue $166M, Net income $(31.1)M — 10-Q Summary
Vital Farms, Inc. (VITL) reported its Q2 2026 financial results, showing a revenue of $166 million, a 10% decrease year-over-year, and a net loss of $(31.1) million, a significant drop from the previous year's net income. The company is facing challenges due to oversupply leading to lower prices and has implemented operational changes including workforce reduction, halting farm builds, and winding down a butter line to focus on core egg products. Despite these challenges, Vital Farms maintains its position as a leading pasture-raised egg brand with high household penetration.
Why Vital Farms (VITL) Stock Is Up Today
Shares of Vital Farms (VITL) rose by 3.9% despite the company reporting a disappointing second quarter with a significant revenue drop and a net loss. The poor performance was attributed to a massive contraction in gross margin, although the company reaffirmed its full-year revenue guidance. The stock has been volatile, and its current price is significantly below its 52-week high, indicating investor concern about its future amidst inflationary pressures and rising input costs.
VITL Q2 FY2026 earnings call
Vital Farms (VITL) reported a 10.1% year-over-year net revenue decline in Q2 FY2026 to $166.0 million, with a significant adjusted EBITDA loss of $26.6 million, attributing the results to industry-wide egg oversupply and price-gap challenges. Despite the downturn, management reaffirmed full-year guidance for net revenue between $775-800 million and adjusted EBITDA of $0-10 million, citing decisive actions such as farmer contract amendments, narrowed price gaps, and SG&A reductions. The company anticipates sequential improvement in Q3 and expects to exit Q4 with a 30% gross margin, driven by distribution gains and cost savings initiatives, while pausing construction on a major facility to conserve capital.
Vital Farms (NASDAQ:VITL) Rating Increased to Buy at Benchmark
Benchmark has upgraded Vital Farms (NASDAQ:VITL) from a "hold" to a "buy" rating, despite the broader analyst consensus remaining "hold" with an average price target of $24.08. Vital Farms' shares rose 1.0% to $12.37, though this is significantly below its 12-month high of $53.13. The company reported quarterly revenue of $166.03 million, exceeding expectations, but experienced a 10.2% year-over-year decline.
Earnings call transcript: Vital Farms misses Q2 2026 estimates as shares fall
Vital Farms (VITL) reported a wider-than-expected Q2 2026 loss and lower revenue, missing analyst estimates due to industry oversupply, higher supply-management costs, and one-time turnaround expenses. Shares fell over 6% following the announcement, trading well below their 52-week high. Despite the miss, management reaffirmed full-year guidance, anticipating a financial trough in Q2 and sequential improvement in the second half of 2026 driven by narrower price gaps, distribution gains, and cost reductions.
Vital Farms (VITL) Reports Q2 Loss, Beats Revenue Estimates
Vital Farms (VITL) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, contrasting with earnings of $0.36 per share a year ago. However, the company surpassed revenue estimates, posting $166.03 million against a consensus of $165.61 million. Despite beating revenue, the stock has underperformed the market significantly this year, and its current Zacks Rank #4 (Sell) suggests expected underperformance in the near future.
Silver Point Leads $125 Million Term Loan Financing for Vital Farms
Silver Point Capital's Direct Lending business has led a $125 million term loan financing for Vital Farms (Nasdaq: VITL), a Certified B Corporation known for ethically produced foods. This financing, alongside a new asset-based revolving credit facility from J.P. Morgan, will provide Vital Farms with additional liquidity to support its next phase of growth. Silver Point will act as the sole lender and administrative agent for the term loan.
Vital Farms Q2 2026 earnings: Egg oversupply cuts gross margin to 6.6%
Vital Farms (NASDAQ: VITL) reported a significant decline in its Q2 2026 financial performance, with net revenue down 10.1% and diluted EPS swinging to a $0.72 loss. The primary driver for this downturn was an egg oversupply, which led to lower-priced channel sales and a contraction in gross margin to 6.6% from 38.9%. Despite these challenges, the company reiterated its fiscal 2026 revenue and adjusted EBITDA guidance, banking on improved shell egg volume and cost-saving initiatives in the second half of the year.
Egg oversupply drives Vital Farms to a $31.1M Q2 loss
Vital Farms (Nasdaq: VITL) reported a Q2 2026 net loss of $31.1 million, a significant drop from a net income of $16.6 million in Q2 2025, primarily due to industry-wide egg oversupply and lower retail prices. Despite a 10.1% decrease in net revenue to $166.0 million, the company successfully grew its dollar share in the shell egg category by over 200 basis points. Vital Farms has implemented a recovery plan, including supply control and cost-saving initiatives, and secured new credit facilities totaling $185 million, while reiterating its fiscal year 2026 net revenue outlook of $775 million to $800 million.
Insiders Could Have Profited By Holding onto Vital Farms Shares Despite 11% Drop
Vital Farms (NASDAQ:VITL) has seen its stock drop by 11% recently. Insiders who sold US$18 million worth of shares over the past year at an average price of US$50.78 would have been better off holding, as the current share price is US$12.15. Despite this, insiders have bought US$422k worth of shares in the last quarter, indicating confidence and strong insider ownership.
Bronstein, Gewirtz & Grossman, LLC Encourages Vital Farms, Inc. (VITL) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Vital Farms, Inc. (NASDAQ:VITL) regarding alleged corporate wrongdoing. The firm encourages investors who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them for more information and to assist in the investigation. The representation of investors in class actions is on a contingency fee basis.
Vital Farms (VITL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Vital Farms (VITL), an egg and butter company, is scheduled to report its Q2 earnings this Thursday morning. The market anticipates a 10.8% year-on-year revenue decline, a reversal from the previous year's increase, and analysts have largely maintained their estimates. Despite Vital Farms' stock being down 5.1% over the last month, the broader perishable food segment has seen positive investor sentiment.
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Class A
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) and certain officers, alleging federal securities law violations. The lawsuit claims Vital Farms made misleading statements regarding delays in its new ERP system rollout, which caused the company to miss its 2025 earnings guidance. Investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, are encouraged to join the suit, with a lead plaintiff deadline of May 26, 2026.
VITL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vital Farms, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) on behalf of investors who suffered losses from May 8, 2025, to February 26, 2026. The lawsuit alleges that Vital Farms made false and misleading statements regarding delays and impacts related to its new ERP system, causing the company to miss its full-year 2025 earnings guidance. Investors have until May 26, 2026, to request to be appointed as lead plaintiff in the case.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Vital Farms, Inc. (VITL) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vital Farms, Inc. (NASDAQ:VITL) securities who bought prior to May 8, 2025, and still hold their shares. The investigation focuses on whether Vital Farms and its officers/directors engaged in corporate wrongdoing. The firm is encouraging affected shareholders to connect to assist with the investigation, offering representation on a contingency fee basis.
Telsey maintains Vital Farms stock rating amid inventory challenges By Investing.com
Telsey Advisory Group has reiterated a Market Perform rating on Vital Farms (NASDAQ:VITL) shares with an $11.00 price target, despite the stock trading below its InvestingPro Fair Value of $17.61. The firm lowered its sales and adjusted EBITDA forecasts for Vital Farms for Q2 and full-year 2026, citing inventory challenges in the egg industry and increased competition. Vital Farms is responding by adjusting egg supply, expanding distribution, narrowing price gaps, and reducing costs.
(VITL) Price Dynamics and Execution-Aware Positioning
This article analyzes Vital Farms Inc. (NASDAQ: VITL) focusing on its price dynamics and execution-aware positioning. It identifies weak near-term sentiment, no clear price positioning, and potential upside due to the absence of resistance levels above the current price. The analysis includes AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) and multi-timeframe signal analysis.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vital Farms, Inc. (VITL) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Vital Farms, Inc. (VITL). The firm is encouraging shareholders who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them to assist with the investigation. The investigation aims to restore investor capital and ensure corporate accountability.
Vital Farms, Inc. (NASDAQ:VITL) Receives Average Recommendation of "Hold" from Brokerages
Vital Farms, Inc. (NASDAQ:VITL) has an average "Hold" recommendation from fifteen brokerages, with an average 12-month price target of $24.08, despite recent analyst downgrades and reduced price targets. The company missed its quarterly EPS estimates but saw a 15.4% year-over-year revenue increase. Insiders have recently purchased shares, totaling 38,700 shares worth approximately $320,864 in the past three months.
Analysts Estimate Vital Farms (VITL) to Report a Decline in Earnings: What to Look Out for
Vital Farms (VITL) is projected to report a year-over-year decline in earnings and revenue for the quarter ending June 2026, with an expected loss of $0.45 per share and revenues of $171.13 million. The Zacks Earnings ESP is -2.57% and the stock carries a Zacks Rank #5 (Strong Sell), making it difficult to predict an earnings beat. Investors are advised to consider other factors beyond just earnings surprise ahead of the report, due around August 6.
Vital Farms, Inc. (VITL) is Attracting Investor Attention: Here is What You Should Know
Vital Farms (VITL) is currently a highly-watched stock, showing an 11.1% gain over the past month, outperforming the S&P 500 and its industry. Despite this, the company faces significant challenges, including expected losses for the current quarter and fiscal year, as reflected by its Zacks Rank #5 (Strong Sell). Investors are advised to consider the company's declining earnings estimates and D grade in valuation, suggesting potential underperformance in the near term.
Vital Farms Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs reports that Vital Farms (NASDAQ: VITL) had 757 employees worldwide as of March 2026, representing a 25% growth from 2023. The company is actively hiring with 37 job postings and an average salary of $75,472. The majority of its workforce is in North America, and employee sentiment is neutral but improving.
Vital Farms Inc (VITL) Institutional Confidence
Vital Farms Inc (VITL) has an institutional shareholding score of 10.00, placing it first in the Food & Drug Retailing industry. Institutional shareholding increased by 19.36% quarter-over-quarter, reaching 124.59%. First Eagle Investment is the largest institutional shareholder with 737.00K shares, representing 1.21% of outstanding shares.
Vital Farms, Inc. (VITL) Q4 2022 Earnings Report - Results, Call & Slides
This article details Vital Farms, Inc.'s Q4 2022 earnings report, highlighting that the company beat consensus estimates for both EPS and revenue. Vital Farms reported an actual EPS of $0.04 against a consensus of $0.03, and actual revenue of $110.08 million against an expected $100.27 million, marking a 42.21% year-over-year revenue growth. The report also provides information on upcoming earnings dates and access to the earnings call audio and slide deck.
Vital Farms, Inc. (VITL) Investigation: Bronstein, Gewirtz & Gros
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Vital Farms, Inc. (VITL) for potential corporate wrongdoing. The firm is encouraging investors who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them to assist with the investigation. The firm operates on a contingency fee basis for class actions.
Vital Farms Inc (VITL) Risk Assessment: Volatility, Financial Risk & Investment Risk
Vital Farms Inc (VITL) has a risk assessment score of 5.42, ranking 16 out of 30 in the Food & Drug Retailing industry. Its beta of 1.12 indicates higher volatility compared to the S&P 500. The article details various risk metrics including maximum drawdown, volatility, Sharpe Ratio, and liquidity indicators.
Vital Farms (VITL) Laps the Stock Market: Here's Why
Vital Farms (VITL) has shown strong stock performance, outperforming the S&P 500 and the Consumer Staples sector. The company is preparing for its upcoming earnings report on August 6, 2026, with projected decreases in both EPS and revenue compared to the previous year. Despite a strong past performance, the stock currently holds a Zacks Rank of #4 (Sell), reflecting recent negative revisions to analyst estimates and placing it in a low-ranking industry.
Vital Farms (VITL) Laps the Stock Market: Here's Why
Vital Farms (VITL) closed up 2.07% in the latest trading session, outperforming the S&P 500, Dow, and Nasdaq. The company is scheduled to release its earnings on August 6, 2026, with projected EPS of -$0.45 and revenue of $171.13 million, representing significant decreases from the prior year. Despite recent stock gains, Vital Farms currently holds a Zacks Rank of #4 (Sell) due to negative short-term analyst estimate revisions.
VITL|Vital Farms Inc|Price:13.290|
Vital Farms Inc (VITL) has healthy fundamentals and high growth potential, though its valuation is fair for its industry. Institutional ownership is very high, and analysts currently rate it as "Hold" with a target price of $12.00. Despite strong stock market performance and outperforming fundamentals, technical analysis suggests the stock is currently range-bound.
Vital Farms, Inc. Revenue Breakdown – FWB:5KH
Vital Farms, Inc. (FWB:5KH) generated 646.60 million EUR last year, with its Eggs and Egg-related Products segment being the primary contributor at 624.24 million EUR. The revenue largely originated from the United States, which accounted for the entire 646.60 million EUR in sales.
Vital Farms, Inc. (VITL) Stock forecasts
The article provides a stock forecast page for Vital Farms, Inc. (VITL), though the main content is a summary of Vickers Top Insider Picks report for July 20, 2026. This report identifies 25 companies with strong insider purchase histories using a proprietary algorithm, spanning various sectors. It also lists several related analyst reports for companies like Intel Corp and American Airlines Group Inc.
Vital Farms Inc (VITL) Cash Flow
This article provides a detailed cash flow statement for Vital Farms Inc (VITL), covering quarterly and annual data from FY2019Q1 to FY2026Q1. It includes breakdowns of operating, investing, and financing cash flows, along with related metrics like net income, capital expenditures, and free cash flow. The article also features an FAQ section explaining key cash flow concepts and their relevance to VITL.
Vital Farms, Inc. (VITL) Stock forecasts
The article mentions Vital Farms, Inc. (VITL) in its title but primarily contains navigation, ads, and market data for other companies. It briefly introduces "The Vickers Top Insider Picks" report, which identifies companies with compelling insider purchase histories. No specific forecast information for Vital Farms, Inc. (VITL) is present in the provided content.
Vital Farms Inc (VITL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for Vital Farms Inc (VITL), categorizing its income by business segments and regional contributions. As of April 6, the company's revenue is predominantly from "Eggs" at 96.54%, with the remaining 3.46% from "Butter," and 100% of its revenue originates from the "United States" region. The data is presented for various fiscal years and quarters, with the latest update on April 6.
Vital Farms Inc (VITL) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides details on the dividend history of Vital Farms Inc (VITL), noting that no dividends have been distributed in the past five years. It also includes current stock performance data, market capitalization, and P/E ratio for Vital Farms Inc. The piece serves as a concise report on VITL's dividend policy and key financial metrics.
Vital Farms Inc (VITL) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Vital Farms Inc (VITL), highlighting its current earnings forecast score of 6.83 which ranks 16th in the Food & Drug Retailing industry. The average analyst price target for VITL is $52.00, with a range of $45.00 to $60.00, and analysts currently rate the stock as a "Hold." The company's expected revenue for the next quarter is $163.87M, with an expected EPS of -$0.45.
Vital Farms to Report Second Quarter 2026 Financial Results on August 6, 2026
Vital Farms (Nasdaq: VITL) will report its second-quarter 2026 financial results on August 6, 2026, before the market opens. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results, with details available on their investor relations website. Vital Farms is a Certified B Corporation known for its ethically produced foods, including pasture-raised eggs.
Vital Farms Inc (VITL) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Vital Farms Inc (VITL), highlighting its current valuation score, P/E ratio, and industry ranking. As of July 23, 2026, VITL has a valuation score of 6.62, placing it 28 out of 30 in the Food & Drug Retailing industry. The P/E ratio is noted at 11.91, significantly below its recent high but above its recent low.
